COVID-19 Outbreak, Mitigation, and Governance in High Prevalent Countries
By: Lung-Chang Chien and Ro-Ting Lin
References
- World Health Organization. Coronavirus disease (COVID-2019) situation reports.
www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports . Accessed May 10, 2020. - Cascella M, Rajnik M.
Features, evaluation and treatment coronavirus (COVID-19) . Treasure Island, FL: StatPearls; 2020. - Chen WH, Strych U. The SARS-CoV-2 vaccine pipeline: An overview. Curr Trop Med Rep; 2020: 1–4. DOI: 10.1007/s40475-020-00201-6
- Amanat F, Krammer F. SARS-CoV-2 vaccines: Status report. Immunity. 2020; 52(4): 583–9. DOI: 10.1016/j.immuni.2020.03.007
- Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5): 305–6. DOI: 10.1038/d41573-020-00073-5
- Kaufmann D, Kraay A.
Governance matters VIII: Aggregate and individual governance indicators 1996–2008 . Washington, DC, USA: The World Bank; 2009. DOI: 10.1596/1813-9450-4978 - George A, LeFevre AE, Jacobs T, et al. Lenses and levels: The why, what and how of measuring health system drivers of women’s, children’s and adolescents’ health with a governance focus. BMJ Glob Health. 2019; 4: 11. DOI: 10.1136/bmjgh-2018-001316
- Mackenbach JP, McKee M. Government, politics and health policy: A quantitative analysis of 30 European countries. Health Policy. 2015; 119(10): 1298–308. DOI: 10.1016/j.healthpol.2015.08.017
- Ruiz-Cantero MT, Guijarro-Garvi M. Governance commitment to reduce maternal mortality. A political determinant beyond the wealth of the countries. Health Place. 2019; 57: 313–20. DOI: 10.1016/j.healthplace.2019.05.012
- Wehrmeister FC, da Silva ICM. Is governance, gross domestic product, inequality, population size or country surface area associated with coverage and equity of health interventions? Ecological analyses of cross-sectional surveys from 80 countries. BMJ Glob Health. 2017; 2(4):
e000437 . DOI: 10.1136/bmjgh-2017-000437 - Lin RT, Chien LC. Governance matters: An ecological association between governance and child mortality. Int Health. 2014; 6(3): 249–57. DOI: 10.1093/inthealth/ihu018
- Gates B. Responding to COVID-19 – A once-in-a-century pandemic? N Engl J Med. 2020; 382(18): 1677–9. DOI: 10.1056/NEJMp2003762
- Amnesty International.
Eastern Europe and Central Asia confronted with COVID-19: Responses and responsibilities . London, UK; 2020. - Kraemer MUG, Yang CH, Gutierrez B, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020; 368(6490): 493–7. DOI: 10.1126/science.abb4218
- The Office of the High Commissioner for Human Rights (UN Human Rights). COVID-19 guidance. 2020.
https://www.ohchr.org/Documents/Events/COVID-19_Guidance.pdf . Accessed May 10, 2020. - Kupferschmidt K, Cohen J. Can China’s COVID-19 strategy work elsewhere? Science. 2020; 367(6482): 1061–2. DOI: 10.1126/science.367.6482.1061
- Linde J, Peters Y. Responsiveness, support, and responsibility: How democratic responsiveness facilitates responsible government. Party Politics. 2020; 26(3): 291–304. DOI: 10.1177/1354068818763986
- The worldwide governance indicators. 2019.
https://info.worldbank.org/governance/wgi/ .https://info.worldbank.org/governance/wgi/Home/downLoadFile?fileName=wgidataset.xlsx . Accessed April 1, 2020. - Dong E, Du H. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020; 20(5): 533–4. DOI: 10.1016/S1473-3099(20)30120-1
- Current world population.
https://www.worldometers.info/world-population/ . Accessed April 23, 2020. - Kim HJ, Fay MP. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3): 335–51. DOI: 10.1002/(SICI)1097-0258(20000215)19:3<;335::AID-SIM336>3.0.CO;2-Z
- Surveillance Research Program, National Cancer Institute. Average annual percent change (AAPC) and confidence interval.
https://surveillance.cancer.gov/help/joinpoint/setting-parameters/method-and-parameters-tab/apc-aapc-tau-confidence-intervals/average-annual-percent-change-aapc . Accessed June 22, 2020. - Rajan D, Koch K, Rohrer K, et al. Governance of the COVID-19 response: A call for more inclusive and transparent decision-making. BMJ Glob Health. 2020; 5(5). DOI: 10.1136/bmjgh-2020-002655
- Oh J, Lee JK. National response to COVID-19 in the Republic of Korea and lessons learned for other countries. Health Syst Reform. 2020; 6(1):
e1753464 . DOI: 10.1080/23288604.2020.1753464 - Rahimi F, Talebi Bezmin Abadi A. Transparency and information sharing could help abate the COVID-19 pandemic. Infect Control Hosp Epidemiol; 2020: 1–2. DOI: 10.1017/ice.2020.174
- World Health Organization.
Strengthening and adjusting public health measures throughout the COVID-19 transition phases . Copenhagen, Denmark: WHO Regional Office for Europe; 2020. - Kaul I, Faust M. Global public goods and health: Taking the agenda forward. Bull World Health Organ. 2001; 79(9): 869–74.
- Bollyky TJ, Gostin LO. The Equitable Distribution of COVID-19 Therapeutics and Vaccines. JAMA; 2020. DOI: 10.1001/jama.2020.6641
- Tchakarova V. The COVID-19 crisis and the Austrian response; 2020.
https://www.orfonline.org/expert-speak/the-covid-19-crisis-and-the-austrian-response-64344/ . Accessed May 11, 2020. - Tsang TK, Wu P. Effect of changing case definitions for COVID-19 on the epidemic curve and transmission parameters in mainland China: A modelling study. Lancet Public Health. 2020; 5(5): e289–e296. DOI: 10.1016/S2468-2667(20)30089-X
- Baird RP. Why widespread coronavirus testing isn’t coming anytime soon. March 24, 2020.
https://www.newyorker.com/news/news-desk/why-widespread-coronavirus-testing-isnt-coming-anytime-soon . - Velavan TP, Meyer CG. The COVID-19 epidemic. Trop Med Int Health. 2020; 25(3): 278–80. DOI: 10.1111/tmi.13383
- Cheng HY, Jian SW, Liu DP, et al. Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset. JAMA Intern Med; 2020. DOI: 10.1001/jamainternmed.2020.2020
- Wang CJ, Ng CY. Response to COVID-19 in Taiwan: Big data analytics, new technology, and proactive testing. JAMA; 2020. DOI: 10.1001/jama.2020.3151
- Esposito S, Principi N. To mask or not to mask children to overcome COVID-19. Eur J Pediatr; 2020. DOI: 10.1007/s00431-020-03674-9
- Ngerng R. Taiwan’s response to COVID-19 is a lesson in managing risk. April 24, 2020.
https://international.thenewslens.com/article/134301 . Accessed May 10, 2020. - Cheng HY, Li SY. Initial rapid and proactive response for the COVID-19 outbreak – Taiwan’s experience. J Formos Med Assoc. 2020; 119(4): 771–3. DOI: 10.1016/j.jfma.2020.03.007
- Kaufmann D, Kraay A. Governance indicators: Where are we, where should we be going? The World Bank Research Observer. 2008; 23(1): 1–30. DOI: 10.1093/wbro/lkm012
DOI: https://doi.org/10.5334/aogh.3011 | Journal eISSN: 2214-9996
Language: English
Published on: Sep 17, 2020
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
© 2020 Lung-Chang Chien, Ro-Ting Lin, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.